EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions

Jessica Conley iD, Benjamin Genenger iD, Bruce Ashford iD, Marie Ranson iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25158493 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Jessica Conley und 3 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2500, Australia. Hauptthemen laut MEDLINE: MicroRNAs, Keratinocytes, Skin Neoplasms, Basal Cell Carcinoma. Die Arbeit nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Cancer Institute of New South Wales, University of Wollongong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The keratinocyte carcinomas, basal cell carcinoma (BCC), and cutaneous squamous cell carcinoma (cSCC), are the most common cancers in humans. Recently, an increasing body of literature has investigated the role of miRNAs in keratinocyte carcinoma pathogenesis, progression and their use as therapeutic agents and targets, or biomarkers. However, there is very little consistency in the literature regarding the identity of and/or role of individual miRNAs in cSCC (and to a lesser extent BCC) biology. miRNA analyses that combine clinical evidence with experimental elucidation of targets and functional impact provide far more compelling evidence than studies purely based on clinical findings or bioinformatic analyses. In this study, we review the clinical evidence associated with miRNA dysregulation in KCs, assessing the quality of validation evidence provided, identify gaps, and provide recommendations for future studies based on relevant studies that investigated miRNA levels in human cSCC and BCC. Furthermore, we demonstrate how miRNAs contribute to the regulation of a diverse network of cellular functions, and that large-scale changes in tumor cell biology can be attributed to miRNA dysregulation. We highlight the need for further studies investigating the role of miRNAs as communicators between different cell types in the tumor microenvironment. Finally, we explore the clinical benefits of miRNAs as biomarkers of keratinocyte carcinoma prognosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsKeratinocytesSkin NeoplasmsBasal Cell CarcinomaGene Expression Regulation, NeoplasticCarcinoma, Squamous CellBiomarkers, TumorHumansTumor MicroenvironmentPrognosis

Stichwörter der Autor:innen

basal cell carcinomacutaneous squamous cell carcinomakeratinocyte carcinomamiRNAmicro RNAnon-melanoma skin cancer

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Molecular Horizons, School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong, NSW 2500, Australia.
  • Illawarra Shoalhaven Local Health District (ISLHD), NSW Health, Wollongong, NSW 2500, Australia.
  • Graduate School of Medicine, University of Wollongong, Wollongong, NSW 2500, Australia.

ORCID-Profile: Jessica Conley, Benjamin Genenger, Bruce Ashford, Marie Ranson

Förderung

  • National Health and Medical Research Council
  • Cancer Institute of New South Wales
  • University of Wollongong
  • NHMRC Ideas Grant
  • University Postgraduate Award (University of Wollongong)
  • HDR career launch scholarship (University of Wollongong)
  • Cancer Institute NSW Translational Program Grant

Zitieren

APA

Conley, J., Genenger, B., Ashford, B., & Ranson, M. (2024). Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158493

Vancouver

Conley J, Genenger B, Ashford B, Ranson M. Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158493

BibTeX
@article{Conley2024,
  author = {Conley, Jessica and Genenger, Benjamin and Ashford, Bruce and Ranson, Marie},
  title = {Micro RNA Dysregulation in Keratinocyte Carcinomas: Clinical Evidence, Functional Impact, and Future Directions},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25158493}
}
Kostenlos starten →